GoodRead
Next Monday was also the first day of school for the kids. Zander would be in charge of taking the children to
school, so the only thing that needed to be done in the morning was to prepare breakfast for them.
Luca figured that she could do it alone, so she agreed to Aunt Neile’s ask.
"Okay, thank you, Dr. Craw." Aunt Neile breathed a sigh of relief.
"It's nothing. If there’s nothing else you want to talk about, I have to head to the office now. By the way, when Mr.
Crawford goes to work, please remind him to bring along his coffee," Luca reminded her.
"Okay, Ms. Craw." Aunt Neile watched Luca leave, and the corners of her mouth rose slightly.
She was glad that Luca agreed. Otherwise, she would have to trouble others to send her grandson to school.
After she stepped out of the villa, Luca got into Warren's car and headed to the office.
It was a big day for Watson Biopharmaceuticals. The drug developed was classified as medical insurance drugs, so
they would discuss the price with the relevant government departments so it could be listed.
The final price of the drug would affect the company's operating profit and the bonus her research group ultimately
received.
After she arrived at the office, Luca returned to the office and put down the briefcase. She then went to the
Follow on NovᴇlEnglish.nᴇtlaboratory and waited to know the final price of the drug with the research team.
The drug pricing and listing were all done by other departments, so everyone in the research team could only wait
for their colleagues to announce the final price.
Finally, the price was decided after some discussion.
The crowd cheered.
The price was very reasonable. The government did not set it too low, so the bonus they would receive would be
quite generous.
"Great, it's a fair price," Rhett said. He had been exposed to drug pricing, so he knew the reasonable price range.
He looked at Luca. Everyone was smiling, but she was silently looking at a document. Her mood was not influenced
by the announcement of the price of the drug.
Rhett could not help but sigh in his heart at how Luca was different from the others.
No matter how experienced professors were, they would smile with satisfaction when the drugs they researched
got a reasonable price. It was a kind of affirmation for their drug research.
Few were like Luca, who had an indifferent expression.
"Dr. Craw, congratulations." A researcher leaned over and congratulated her.
Luca closed the document and nodded lightly. "This is a drug developed by everyone on the team. Congratulations
to everyone for getting confirmation from the government and relevant departments."
Her research was built on Shanks' research.
Although the drugs developed by Shanks lacked a lot of clinical steps, most of them were reliable and their efficacy
was better than many drugs on the market.
Therefore, her research was much better than other drugs and the clinical data was also positive, so the price was
higher than their competitors in the market.
After the patent application gets approved, Watson Biopharmaceuticals would obtain significant profits.
Luca looked at the contract being signed on the screen and breathed a sigh of relief.
This time, Abel could not hurt Watson Biopharmaceuticals.
As she thought of that, Luca could not help but wonder why Abel insisted on having her research this project.
She knew that there were biopharmaceutical companies under Abel's name.
They were a lot bigger than Watson Biopharmaceuticals.
If he had kept the project for his companies, the profits would have been umpteen.
Instead, he gave the project to Watson Biopharmaceuticals and did not sabotage it. What in the world was he
Follow on Novᴇl-Onlinᴇ.cᴏmplotting?
‘Isn't he going to take Luke on?’
At how things went, he was not messing with Luke. Rather, he was promoting the stable growth of Watson
Biopharmaceuticals and T Corporation.
Luca could not help but wonder what Abel had up his sleeves.
She stood up and walked out.
The researchers in the lab looked at each other. One of them could not help but wonder, "Is Dr. Craw dissatisfied
with the price of the drug?"
"No, it's a bit higher than we expected. Dr. Craw doesn't look dissatisfied," another researcher said.
"Is it? Why isn’t she smiling, then? She’s as indifferent as a bystander..."
"You're wrong. If she were a bystander, she would be jealous, not indifferent. We have the highest price for similar
drugs in the market. If others hear about it, how can they not be jealous?"
"Yes, and the data effect is also the best," another person echoed.
"Then, Dr. Craw is..."
Visit our social media platform to read fascinating stories every day and connect with the community!
